◀ Back to MAPK3

MAPK3 — SST

Text-mined interactions from Literome

Cattaneo et al., FEBS Lett 2000 (MAP Kinase Signaling System...) : In previous studies we have showed that somatostatin (SST) inhibits cell division, mitogen activated protein ( MAP ) kinase and Ras activity in the human neuroblastoma cell line SY5Y
Ballarè et al., J Clin Endocrinol Metab 2001 (Acromegaly...) : Moreover, somatostatin reduced cell growth and MAPK activity in WT but not in mutant cells in which the peptide even increased MAPK activity
Florio et al., Endocrinology 2003 (Neoplasms...) : BN81658 reversed somatostatin inhibition of cell proliferation, NO production, and MAPK activity, indicating that SSTR3 activation is required for the effects of somatostatin in vitro
Pola et al., J Biol Chem 2003 (MAP Kinase Signaling System...) : We have previously shown that somatostatin inhibits cell division and ERK 1/2 and Ras activity in SH-SY5Y cells
Wang et al., Am J Physiol Cell Physiol 2011 : Furthermore, the somatostatin receptor SSTR2 antagonist CYN154806 could abolish somatostatin induced NHE8 expression and p38 MAPK phosphorylation
Duran-Prado et al., Circ Res 2013 (Atherosclerosis...) : Cortistatin inhibited platelet derived growth factor stimulated proliferation of human aortic SMCs via binding to somatostatin receptors ( sst2 and sst5 ) and ghrelin receptor, induction of cAMP and p38-mitogen activated protein kinase , and inhibition of Akt activity
Shimizu et al., J Lipid Mediat Cell Signal 1996 : Platelet activating factor and somatostatin activate mitogen activated protein kinase ( MAP kinase ) and arachidonate release
Florio et al., Mol Endocrinol 1999 : Somatostatin activation of mitogen activated protein kinase via somatostatin receptor 1 (SSTR1)